CENPF promotes papillary thyroid cancer progression by mediating cell proliferation and apoptosis

Papillary thyroid cancer (PTHCA) accounts for ~85% cases of thyroid cancer and exhibits high incidence. Targeted therapy is an effective method to combat this disease; however, novel therapeutic targets are required. Centromere protein F (CENPF), a member of centromere proteins and a transient kinet...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Yong, Xu, Shujian, Cheng, Kai, Diao, Caimei, Liu, Song, Zou, Weiwei, Bi, Yueyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918471/
https://www.ncbi.nlm.nih.gov/pubmed/33680123
http://dx.doi.org/10.3892/etm.2021.9832

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918471/
https://www.ncbi.nlm.nih.gov/pubmed/33680123
http://dx.doi.org/10.3892/etm.2021.9832

Ejemplares similares